Prognostic value of some inflammatory markers in patients with lymphoma

Lymphoma is a group of blood cell tumors which develop from lymphocytes. The main forms of lymphoma are Hodgkin lymphoma (HL) and non-HL (NHL). Cytokines may contribute to lymphoma and they are related to risk NHL and HL. Assessment of the serum level of certain inflammatory markers as complementary...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Bioscience reports 2019-03, Vol.39 (3)
Hauptverfasser:	Hamed Anber, Nahla, El-Sebaie, Ahmed H, Darwish, Noureldien H E, Mousa, Shaker A, Shamaa, Sameh S
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Biomarkers - blood Chemokine CCL2 - blood Cytokines - blood Diagnosis, Differential Female Granulocyte Colony-Stimulating Factor - blood Hodgkin Disease - blood Hodgkin Disease - diagnosis Hodgkin Disease - drug therapy Humans Inflammation Mediators - blood Lymphoma, Non-Hodgkin - blood Lymphoma, Non-Hodgkin - diagnosis Lymphoma, Non-Hodgkin - drug therapy Male Middle Aged Outcome Assessment, Health Care Prognosis Sensitivity and Specificity Tumor Necrosis Factor-alpha - blood
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!